Panel Discussion: Evaluating Current Strategies for ALS Target Identification: What are the Avenues to Still Prioritise?

Time: 10:30 am
day: Day One AM


  • Outlining current avenues of disease pathology to identify and validate targets for familial and sporadic ALS
  • Processing disease pathology information to validate genetic ALS targets
  • Where are the current innovations for novel target identification?